@mRNAcore

A collaborative initiative to develop the mRNA technologies of the future.

 Melbourne, Victoria, Australia
Joined August 2024
  • Tweets11
  • Following15
  • Followers9
🚨 New paper out in JEM! In collab with Jo Groom’s lab @WEHI_research, we show that transient IFNAR blockade enhances CD8+ TSCM cell formation & vaccine protection post mRNA-LNP vaccination. Fine-tuning inflammation = better memory. Full article here📖 bit.ly/4l42BXE

Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection

Broomfield et al. demonstrate that early type I interferon blockade alters CXCR3 chemokine regulation and cell location to promote an antigen-dependent CD8

rupress.org
18
Exciting news! The mRNA Core has officially launched its website! 🎉 🔬 Discover our cutting-edge mRNA capabilities 🤝 Explore collaboration opportunities 🧬 Stay updated on groundbreaking research Check it out now: mrnacore.org #mRNA #Biotech #MedicalResearch #Monash
15
Breakthrough at Monash! MIPS researchers developed Australia’s 1st #mRNA #COVID19 #vaccine candidates in just 4 weeks using cutting-edge #genetic tech. Prof. Pouton highlights the need for a rapid mRNA platform to tackle future health crises. Read more ➡ bit.ly/3AXBcnI

Melbourne researchers use cutting-edge technology to produce three new COVID-19 vaccine candidates

monash.edu
32
🔬Tackling #Immune Imprinting in #COVID19 #Vaccines: Our research group is addressing immune imprinting, which can hinder protection against new variants. Led by Prof @ColinPouton at @MonashUni, we’ve developed Aus' first mRNA vaccine candidate that shows promise against #Omicron
1
1
29
We seek #collaborations to advance next-gen vaccines. To learn more, click👉lnkd.in/g4SQ9Rh9

LinkedIn

This link will take you to a page that’s not on LinkedIn

lnkd.in
22
Exciting news! Thrilled that Dr. @Emily_Pilk & Prof. @ColinPouton are part of 2 of the 6 @nhmrc #SynergyGrants approved for 2025! Their work is key to advancing groundbreaking #healthcare research🙌This funding highlights the power of #collaboration in driving #innovation
29
Excited to share that @IDTAus has successfully manufactured our #mRNA COVID-19 vaccine candidate, now ready for Phase 1 clinical trials with the @TheDohertyInst next year! 🙌
2
32
This milestone reflects the strength of Victoria's mRNA ecosystem and our commitment to developing #innovative #therapeutics. Big thanks to our collaborators and the support from the @VicGovAu and Federal Governments for making this possible. 🔗bit.ly/3NyFa9h

Successful manufacture of Monash’s COVID-19 mRNA vaccine candidate

monash.edu
28
We’re excited to launch our account & share our mission! Based at MIPS, we lead mRNA innovation in Australia, supporting 20+ collaborators with native & modified mRNA
1
20
Our team developed Australia’s first mRNA COVID-19 vaccine & advances mRNA tech with cutting-edge tools. Funded by MRFF & NCRIS, and a key TIA RNA Products node, we’re shaping mRNA’s future
1
23
Follow us for updates! #mRNA #PharmaceuticalSciences #Innovation #MonashMIPS
16
Load more